molsidomine has been researched along with Cardiac Diseases in 5 studies
Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Molsidomine was unable to significantly attenuate mortality, development of heart failure and morphological damage induced by DAU." | 5.43 | Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings? ( Adamcová, M; Bureš, J; Hroch, M; Jansová, H; Jirkovská-Vávrová, A; Jirkovský, E; Kovaříková, P; Lenčová-Popelová, O; Mazurová, Y; Pokorná, Z; Reimerová, P; Šimůnek, T; Štěrba, M; Vostatková, L, 2016) |
| "Molsidomine was unable to significantly attenuate mortality, development of heart failure and morphological damage induced by DAU." | 1.43 | Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings? ( Adamcová, M; Bureš, J; Hroch, M; Jansová, H; Jirkovská-Vávrová, A; Jirkovský, E; Kovaříková, P; Lenčová-Popelová, O; Mazurová, Y; Pokorná, Z; Reimerová, P; Šimůnek, T; Štěrba, M; Vostatková, L, 2016) |
| "Molsidomine was administered sub-lingually to two groups of five patients." | 1.27 | [Acute hemodynamic effects of molsidomine in man]. ( Boutarin, J; Ferrini, M; Ritz, B; Tartulier, M, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lenčová-Popelová, O | 1 |
| Jansová, H | 1 |
| Jirkovský, E | 1 |
| Bureš, J | 1 |
| Jirkovská-Vávrová, A | 1 |
| Mazurová, Y | 1 |
| Reimerová, P | 1 |
| Vostatková, L | 1 |
| Adamcová, M | 1 |
| Hroch, M | 1 |
| Pokorná, Z | 1 |
| Kovaříková, P | 1 |
| Šimůnek, T | 1 |
| Štěrba, M | 1 |
| Cao, Z | 1 |
| Li, Y | 1 |
| Tartulier, M | 1 |
| Ferrini, M | 1 |
| Boutarin, J | 1 |
| Ritz, B | 1 |
| Arnal, JF | 1 |
| Galinier, M | 1 |
| Mazerolles, M | 1 |
| Rami, J | 1 |
| Besombes, JP | 1 |
| Fauvel, JM | 1 |
| Bounhoure, JP | 1 |
| Gaál, J | 1 |
| Vértesi, C | 1 |
| Knopf, E | 1 |
| Körmöczy, PS | 1 |
1 trial available for molsidomine and Cardiac Diseases
| Article | Year |
|---|---|
Nasal nitric oxide concentration is decreased in heart failure patients receiving nitrates.
Topics: Adult; Aged; Female; Heart Diseases; Humans; Male; Middle Aged; Molsidomine; Nasal Cavity; Nitrates; | 1998 |
4 other studies available for molsidomine and Cardiac Diseases
| Article | Year |
|---|---|
Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cardiotonic Agents; Cardiotoxicity; Cell Line, | 2016 |
Potent inhibition of peroxynitrite-induced DNA strand breakage by ethanol: possible implications for ethanol-mediated cardiovascular protection.
Topics: Bacteriophage phi X 174; Bicarbonates; Central Nervous System Depressants; DNA Damage; DNA, Viral; E | 2004 |
[Acute hemodynamic effects of molsidomine in man].
Topics: Adult; Heart; Heart Diseases; Hemodynamics; Humans; Middle Aged; Molsidomine; Myocardial Contraction | 1983 |
Comparison of the cardioprotective effect of nitroglycerin, molsidomine and SIN-1 in rats with cardiac hypoxia.
Topics: Animals; Antihypertensive Agents; Heart Diseases; Hypoxia; Molsidomine; Nitroglycerin; Rats | 1990 |